Literature DB >> 7028243

Bone marrow transplantation for acute myelosclerosis.

J W Smith, H M Shulman, E D Thomas, A Fefer, C D Buckner.   

Abstract

Four patients with acute myelosclerosis were treated with chemoradiotherapy and bone marrow transplantation. Three of the four had prompt engraftment with greater than 0.10 X 10(9) granulocytes/liter three weeks after transplantation. One patient continues in complete remission one year after transplantation. One patient experienced a partial remission and two patients died early in the post-transplantation period. Marrow fibrosis disappeared in three of the four patients. The patient with residual marrow fibrosis died 22 days after transplantation. It is apparent that marrow fibrosis is reversible. In view of the absence of other effective therapy, intensive therapy with marrow transplantation should be considered as primary therapy for patients with acute myelosclerosis who have a suitable marrow donor.

Entities:  

Mesh:

Year:  1981        PMID: 7028243     DOI: 10.1002/1097-0142(19811115)48:10<2198::aid-cncr2820481014>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14.

Authors:  M Winkelmann; C Aul; R E Scharf; A Schmitt-Gräff; F Carbonell; J L Villeval; H Grosse-Wilde; J T Fischer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-11-02

Review 2.  [Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy].

Authors:  H Link; H J Kolb; W Ebell; D K Hossfeld; A Zander; D Niethammer; H Wandt; H Grosse-Wilde; U W Schaefer
Journal:  Med Klin (Munich)       Date:  1997-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.